Host B-cell receptor or antibody specific for Plasmodium circumsporozoite protein epitope

Host B-cell receptors (BCRs) and antibodies recognizing circumsporozoite protein (CSP) epitopes are key components of adaptive immunity that target the major surface antigen on Plasmodium sporozoites, the form of the parasite transmitted by mosquito bite in malaria[4][5][6]. Upon exposure, naïve B-cells expressing BCRs that specifically bind to CSP undergo activation, clonal expansion, and affinity maturation, eventually generating plasma cells that secrete anti-CSP antibodies and memory B-cells for long-term protection[4][5][7]. The antibodies most studied target the immunodominant NANP repeat region of the Plasmodium CSP[1][3][5]. These antibodies and their B-cell precursors can neutralize sporozoite infectivity primarily by blocking the parasite’s ability to invade hepatocytes, a crucial step in the parasite lifecycle[4][6]. Such antibody responses can be induced by infection or vaccination (e.g., RTS,S vaccine)[3][5]. This "target" is conceptually a host immune recognition mechanism, not a discrete molecular drug target like a receptor or enzyme. Instead, it refers broadly to classes of host immunoglobulins or BCRs specific to a microbial antigen (in this case, CSP). While not a conventional target for small molecule drugs, it is central to many vaccine strategies and the development or passive transfer of protective monoclonal antibodies for malaria prevention. There are technical concerns in treating this target as a singular entity: it encompasses large sets of heterogeneous BCRs and antibodies, not a single defined molecule, and "host B-cell receptor and antibody recognizing CSP epitope" is not a canonical molecular name. The target is most correctly described at the epitope specificity level (e.g., "B-cell receptor specific for NANP-repeat epitope of Plasmodium falciparum circumsporozoite protein"). Note: The entity as described is imprecise for many structured databases, as it conflates antibody/BCR class, specificity, and species. For structured purposes, new canonical forms mapping distinct BCR/antibody specificities to defined genomes (such as human anti-NANP antibody, etc.) may be needed. References: [1][2][3][4][5][6][7]

Other names

B-cell receptor recognizing CSP epitopeAntibody to circumsporozoite protein (CSP)

Antigen recognition and binding; Neutralization of Plasmodium falciparum or Plasmodium vivax sporozoites by blocking circumsporozoite protein function; Opsonization